| DE3643987A1
              (de)
            
            * | 1986-12-22 | 1988-06-23 | Lohmann Therapie Syst Lts | Basische, wirkstoffdurchlaessige haftklebende polymermasse, insbesondere zum einsatz mit basischen wirkstoffen, verfahren zu ihrer herstellung und ihre verwendung | 
        
          | DK158336C
              (da)
            
            * | 1987-09-22 | 1990-10-01 | Coloplast As | Forbindsmateriale til behandling af saar samt smaalegemer til brug ved fremstilling deraf | 
        
          | DE3809978A1
              (de)
            
            * | 1988-03-24 | 1989-10-05 | Lohmann Gmbh & Co Kg | Reservoir fuer gesteuerte wirkstoffabgabe, dieses enthaltende vorrichtung, sowie verfahren zu deren herstellung und verwendung der vorrichtung | 
        
          | DE3823070A1
              (de)
            
            * | 1988-07-07 | 1990-02-22 | Kettelhack Riker Pharma Gmbh | Selbstklebendes heftpflaster | 
        
          | US5026556A
              (en)
            
            * | 1988-11-10 | 1991-06-25 | Norwich Eaton Pharmaceuticals, Inc. | Compositions for the transdermal delivery of pharmaceutical actives | 
        
          | DE3908431A1
              (de)
            
            * | 1989-03-15 | 1990-09-27 | Lohmann Therapie Syst Lts | Transdermales system mit gestufter wirkstoffabgabe und verwendung fuer die lokale oder systemische wirkstoffverabreichung | 
        
          | DE3939376C1
              (forum.php)
            
            * | 1989-11-29 | 1991-05-08 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De |  | 
        
          | DE4020144A1
              (de)
            
            * | 1990-06-25 | 1992-01-09 | Lohmann Therapie Syst Lts | Pflaster mit hohem gehalt an weichmachenden inhaltsstoffen | 
        
          | GB9021674D0
              (en)
            
            * | 1990-10-05 | 1990-11-21 | Ethical Pharma Ltd | Transdermal device | 
        
          | DE4110027C2
              (de) | 1991-03-27 | 1996-08-29 | Lohmann Therapie Syst Lts | Verfahren zur Konfektionierung transdermaler therapeutischer Pflaster | 
        
          | GB9207437D0
              (en)
            
            * | 1992-04-03 | 1992-05-20 | Orion Yhtymae Oy | Topical administration of toremifene and its metabolites | 
        
          | DK170792B1
              (da)
            
            * | 1992-08-27 | 1996-01-22 | Coloplast As | Hudpladeprodukt til dosering af et eller flere medikamenter | 
        
          | WO1994007463A1
              (en)
            
            * | 1992-09-25 | 1994-04-14 | Minnesota Mining And Manufacturing Company | Skin treatment with adhesion enhancement properties | 
        
          | US5462743A
              (en)
            
            * | 1992-10-30 | 1995-10-31 | Medipro Sciences Limited | Substance transfer system for topical application | 
        
          | DE4333595A1
              (de)
            
            * | 1993-10-01 | 1995-04-06 | Labtec Gmbh | Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut | 
        
          | DE4407742C1
              (de)
            
            * | 1994-03-08 | 1995-06-22 | Hexal Pharma Gmbh | Transdermales System in Form eines Pflasters mit einem Tamoxifen-Derivat | 
        
          | FR2719770A1
              (fr)
            
            * | 1994-05-11 | 1995-11-17 | Lhd Lab Hygiene Dietetique | Système matriciel pour administration transdermique d'ibuprofène et procédé de préparation. | 
        
          | GB2292520B
              (en)
            
            * | 1994-08-25 | 1998-09-02 | Univ Sheffield | Transdermal dressings for animals | 
        
          | US5840327A
              (en)
            
            * | 1995-08-21 | 1998-11-24 | Alza Corporation | Transdermal drug delivery device having enhanced adhesion | 
        
          | DE19541260A1
              (de)
            
            * | 1995-11-06 | 1997-05-07 | Lohmann Therapie Syst Lts | Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut | 
        
          | US5730721A
              (en) | 1996-01-25 | 1998-03-24 | Vesture Corporation | Medical applicator and method | 
        
          | DE19606025C2
              (de)
            
            * | 1996-02-19 | 2000-03-30 | Wolfram Sterry | Verfahren und Vorrichtung zur in vivo-Bestimmung optischer Strahlung innerhalb und unterhalb der Epidermis | 
        
          | DE19650471A1
              (de)
            
            * | 1996-12-05 | 1998-06-10 | Beiersdorf Ag | Wirkstoffhaltige Pflaster | 
        
          | DE19706824C1
              (de)
            
            * | 1997-02-21 | 1998-03-26 | Lohmann Therapie Syst Lts | Transdermales oder topisches Plastersystem mit Polyacrylatmatrix mit verbesserten physikalischen Eigenschaften | 
        
          | US5968547A
              (en)
            
            * | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine | 
        
          | US5958447A
              (en)
            
            * | 1998-03-17 | 1999-09-28 | Plc Holding, L.L.C. | Adhesive matrix type transdermal patch and method of manufacturing same | 
        
          | DE19820999A1
              (de)
            
            * | 1998-05-11 | 1999-11-18 | Lohmann Therapie Syst Lts | Laminat zum Aufbringen auf einen Akzeptor | 
        
          | US6043259A
              (en)
            
            * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies | 
        
          | DE19830732B4
              (de)
            
            * | 1998-07-09 | 2008-11-13 | Lts Lohmann Therapie-Systeme Ag | Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung | 
        
          | JP2002539127A
              (ja) | 1999-03-08 | 2002-11-19 | メディキュア  インコーポレーテッド | ビタミンb−6障害のためのピリドキサル類縁体 | 
        
          | DE19911262C2
              (de)
            
            * | 1999-03-13 | 2003-04-10 | Scs Skin Care Systems Gmbh | Vorrichtung zur Abgabe kosmetischer Wirkstoffe | 
        
          | DE19912477A1
              (de)
            
            * | 1999-03-19 | 2000-09-28 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System und Verfahren zu seiner Herstellung | 
        
          | US6183770B1
              (en)
            
            * | 1999-04-15 | 2001-02-06 | Acutek International | Carrier patch for the delivery of agents to the skin | 
        
          | US6328988B1
              (en)
            
            * | 1999-04-23 | 2001-12-11 | Rutgers, The State University Of New Jersey | Hyperbranched polymeric micelles for encapsulation and delivery of hydrophobic molecules | 
        
          | US6417227B1
              (en) | 1999-04-28 | 2002-07-09 | Cg And Associates | Methods of delivery of cetyl myristoleate | 
        
          | US6489345B1
              (en)
            
            * | 1999-07-13 | 2002-12-03 | Medicure, Inc. | Treatment of diabetes and related pathologies | 
        
          | EP1872797A3
              (en)
            
            * | 1999-08-24 | 2008-04-02 | Medicure International Inc. | Treatment of cardiovascular and related pathologies | 
        
          | AU3456101A
              (en)
            
            * | 2000-01-28 | 2001-08-07 | Procter & Gamble Company, The | Cleansing articles containing isolated benefit areas | 
        
          | US7442689B2
              (en)
            
            * | 2000-02-29 | 2008-10-28 | Medicure International Inc. | Cardioprotective phosphonates and malonates | 
        
          | ES2240419T3
              (es) | 2000-02-29 | 2005-10-16 | Medicure International Inc. | Fosfonatos protectores del corazon. | 
        
          | AU784840B2
              (en) | 2000-03-28 | 2006-07-06 | Medicure International Inc. | Treatment of cerebrovascular disease | 
        
          | US6897228B2
              (en)
            
            * | 2000-07-07 | 2005-05-24 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: new uses | 
        
          | US6548519B1
              (en) | 2001-07-06 | 2003-04-15 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: novel uses | 
        
          | WO2002004421A2
              (en) | 2000-07-07 | 2002-01-17 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: cardiovascular therapeutics | 
        
          | DE10056009A1
              (de)
            
            * | 2000-11-11 | 2002-05-16 | Beiersdorf Ag | Hautfreundliches Wirkstoffpflaster zur transdermalen Verabreichung hyperämisierender Wirkstoffe | 
        
          | US20040121988A1
              (en)
            
            * | 2001-03-28 | 2004-06-24 | Medicure International Inc. | Treatment of cerebrovascular disease | 
        
          | FR2822711B1
              (fr)
            
            * | 2001-03-28 | 2003-06-13 | Oreal | Dispositif de traitement comportant une enveloppe definissant une cavite dans laquelle peut-etre engagee une partie du corps | 
        
          | JP4865958B2
              (ja) | 2001-05-23 | 2012-02-01 | 株式会社トクホン | 鎮痛抗炎症局所作用型の貼付剤 | 
        
          | KR20040029359A
              (ko)
            
            * | 2001-07-12 | 2004-04-06 | 루트거스, 더 스테이트 유니버시티 오브 뉴 저지 | 약물 전달을 위한 양친매성 별모양 거대분자 | 
        
          | US20040186077A1
              (en)
            
            * | 2003-03-17 | 2004-09-23 | Medicure International Inc. | Novel heteroaryl phosphonates as cardioprotective agents | 
        
          | EA009623B1
              (ru)
            
            * | 2003-04-30 | 2008-02-28 | Пэдью Фарма Л.П. | Устойчивая к манипуляциям дозировочная форма для трансдермального введения | 
        
          | US8790689B2
              (en)
            
            * | 2003-04-30 | 2014-07-29 | Purdue Pharma L.P. | Tamper resistant transdermal dosage form | 
        
          | US20040219195A1
              (en)
            
            * | 2003-04-30 | 2004-11-04 | 3M Innovative Properties Company | Abuse-resistant transdermal dosage form | 
        
          | US20060286159A1
              (en)
            
            * | 2003-10-17 | 2006-12-21 | Calvert Murrell George A | Treatment of persistent active tendinopathy using transdermal glyceryl trinitrate providing durability of effect | 
        
          | US20070059351A1
              (en)
            
            * | 2003-10-17 | 2007-03-15 | Murrell George A C | Transdermal patches containing a nitric oxide-donor and a second active agent and associated methods | 
        
          | US20060286158A1
              (en)
            
            * | 2003-10-17 | 2006-12-21 | Calvert Murrell George A | Treatment of overuse tendinopathy using transdermal nitric oxide-generating agents | 
        
          | US20070053966A1
              (en)
            
            * | 2003-10-17 | 2007-03-08 | Robert Ang | Medicated orthopedic support structures for treatment of damaged musculoskeletal tissue | 
        
          | US20050181029A1
              (en)
            
            * | 2004-02-18 | 2005-08-18 | Samir Mitragotri | Distributed drug dispensing matrix as a transdermal patch | 
        
          | CN101014357A
              (zh)
            
            * | 2004-07-07 | 2007-08-08 | 麦迪库瑞国际公司 | 利用血小板聚集药物的组合疗法 | 
        
          | US20070060549A1
              (en)
            
            * | 2004-08-10 | 2007-03-15 | Friesen Albert D | Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders | 
        
          | KR20070053267A
              (ko)
            
            * | 2004-08-20 | 2007-05-23 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | 반투명 보호 필름을 갖는 경피 약물 전달 장치 | 
        
          | US8367099B2
              (en) | 2004-09-28 | 2013-02-05 | Atrium Medical Corporation | Perforated fatty acid films | 
        
          | US9000040B2
              (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials | 
        
          | US8312836B2
              (en)
            
            * | 2004-09-28 | 2012-11-20 | Atrium Medical Corporation | Method and apparatus for application of a fresh coating on a medical device | 
        
          | US8124127B2
              (en) | 2005-10-15 | 2012-02-28 | Atrium Medical Corporation | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings | 
        
          | US9801982B2
              (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Implantable barrier device | 
        
          | WO2006036982A2
              (en) | 2004-09-28 | 2006-04-06 | Atrium Medical Corporation | Drug delivery coating for use with a stent | 
        
          | US9801913B2
              (en) | 2004-09-28 | 2017-10-31 | Atrium Medical Corporation | Barrier layer | 
        
          | US9012506B2
              (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials | 
        
          | EP2216018B1
              (en) | 2004-10-21 | 2012-04-04 | Durect Corporation | Transdermal delivery systems | 
        
          | US8252320B2
              (en) | 2004-10-21 | 2012-08-28 | Durect Corporation | Transdermal delivery system for sufentanil | 
        
          | US20060094749A1
              (en)
            
            * | 2004-10-28 | 2006-05-04 | Medicure International Inc. | Substituted pyridoxines as anti-platelet agents | 
        
          | JP2008517956A
              (ja)
            
            * | 2004-10-28 | 2008-05-29 | メディキュア・インターナショナル・インコーポレーテッド | 二重の抗血小板性/抗凝固性ピリドキシン類似体 | 
        
          | US7459468B2
              (en)
            
            * | 2004-10-28 | 2008-12-02 | Medicure International, Inc. | Aryl sulfonic pyridoxines as antiplatelet agents | 
        
          | US7332268B2
              (en)
            
            * | 2005-04-07 | 2008-02-19 | Bio-Rad Laboratories, Inc. | Layered support sheet for high-yield spot cutting from gels or membranes | 
        
          | US9278161B2
              (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier | 
        
          | US9427423B2
              (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles | 
        
          | US20070149485A1
              (en)
            
            * | 2005-11-28 | 2007-06-28 | Medicure International, Inc. | Selected dosage for the treatment of cardiovascular and related pathologies | 
        
          | US20070202155A1
              (en)
            
            * | 2006-02-03 | 2007-08-30 | Cure Therapeutics, Inc. | Low dose no donor-containing transdermal patch | 
        
          | US20070259026A1
              (en)
            
            * | 2006-04-20 | 2007-11-08 | Robert Ang | Vasodialating dressing for use with intravenous catheters | 
        
          | GB0610096D0
              (en)
            
            * | 2006-05-22 | 2006-06-28 | Walker Adam | Anti viral spreader | 
        
          | US20080108351A1
              (en)
            
            * | 2006-11-06 | 2008-05-08 | Ut Starcom, Inc. | Seamless transmission of media traffic for roaming mobile terminals during handoffs | 
        
          | EP2083875B1
              (en) | 2006-11-06 | 2013-03-27 | Atrium Medical Corporation | Coated surgical mesh | 
        
          | US9492596B2
              (en) | 2006-11-06 | 2016-11-15 | Atrium Medical Corporation | Barrier layer with underlying medical device and one or more reinforcing support structures | 
        
          | JP5543963B2
              (ja)
            
            * | 2008-05-27 | 2014-07-09 | ザ  ユニバーシティー  オブ  メルボルン | エウスタキオ管機能障害を有する哺乳動物の治療方法 | 
        
          | US20110038910A1
              (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials | 
        
          | DE102009056746A1
              (de)
            
            * | 2009-12-04 | 2011-06-09 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System für die Verabreichung von Peptiden | 
        
          | WO2012009707A2
              (en) | 2010-07-16 | 2012-01-19 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials | 
        
          | EP2693929B1
              (en) | 2011-04-04 | 2018-09-12 | The Procter and Gamble Company | Home care article | 
        
          | MX355294B
              (es) | 2011-08-15 | 2018-04-12 | Procter & Gamble | Artículos para el cuidado personal que tienen composiciones para el cuidado personal que tienen múltiples zonas amoldables. | 
        
          | US8795695B2
              (en) | 2011-08-15 | 2014-08-05 | The Procter & Gamble Company | Personal care methods | 
        
          | US9867880B2
              (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery | 
        
          | GB201211309D0
              (en)
            
            * | 2012-06-26 | 2012-08-08 | Fujifilm Mfg Europe Bv | Process for preparing membranes | 
        
          | WO2014105480A1
              (en) | 2012-12-28 | 2014-07-03 | Teikoku Pharma Usa, Inc. | Extended buprenorphine transdermal delivery compositions and methods for using the same | 
        
          | US9907738B2
              (en) | 2013-06-27 | 2018-03-06 | The Procter & Gamble Company | Personal care compositions and articles | 
        
          | JP6100752B2
              (ja)
            
            * | 2013-07-25 | 2017-03-22 | 株式会社エイエムジー | 化粧料容器 | 
        
          | WO2016065006A1
              (en) | 2014-10-21 | 2016-04-28 | The Procter & Gamble Company | Kit for improving skin appearance | 
        
          | JP2018506345A
              (ja) | 2015-01-23 | 2018-03-08 | マーシオ マーク アブリュー | 皮膚治療のための装置及び方法 | 
        
          | CN108136230B
              (zh) | 2015-10-22 | 2022-05-13 | 宝洁公司 | 发泡膜的阻隔贴片和改善皮肤外观的方法 | 
        
          | CN108348788B
              (zh) | 2015-10-22 | 2021-11-05 | 宝洁公司 | 发泡膜的阻隔贴片和改善皮肤外观的方法 | 
        
          | RU2737464C2
              (ru) | 2015-12-30 | 2020-11-30 | Кориум Интернэшнл, Инк. | Системы и способы длительного трансдермального введения | 
        
          | US11541018B2
              (en) | 2016-06-23 | 2023-01-03 | Corium, Llc | Adhesive matrix with hydrophilic and hydrophobic domains and a therapeutic agent | 
        
          | CA3032044A1
              (en) | 2016-07-27 | 2018-02-01 | Corium International, Inc. | Donepezil transdermal delivery system | 
        
          | US10751265B2
              (en) | 2017-01-09 | 2020-08-25 | The Procter & Gamble | Barrier patch with soluble film and methods of improving skin appearance | 
        
          | US10857076B2
              (en) | 2017-01-09 | 2020-12-08 | The Procter & Gamble Company | Barrier patch with soluble film and methods of improving skin appearance | 
        
          | WO2018129496A1
              (en) | 2017-01-09 | 2018-07-12 | The Procter & Gamble Company | Barrier patch with soluble film and methods of improving skin appearance | 
        
          | US10959918B2
              (en) | 2017-06-22 | 2021-03-30 | The Procter & Gamble Company | Films including a water-soluble layer and a vapor-deposited coating | 
        
          | CA3086163A1
              (en) | 2017-12-20 | 2019-06-27 | Corium, Inc. | Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point | 
        
          | US10751266B2
              (en) | 2018-03-19 | 2020-08-25 | The Procter & Gamble Company | Method of making a barrier patch with soluble film | 
        
          | DE102021102555A1
              (de) | 2021-02-04 | 2022-08-04 | Lts Lohmann Therapie-Systeme Ag. | Verfahren zur Herstellung eines Formelements für die Herstellung von Mikroarrays sowie Formelement |